Ccla Investment Management / TMO
Ccla Investment Management’s Thermo Fisher Scientific Inc Position
Does Ccla Investment Management own Thermo Fisher Scientific Inc (TMO)? Yes — 267.6K shares worth $155M (+2.49% of its 13F portfolio) as of Q4 2025, down from 301.0K shares the prior filed quarter.
Position Value
$155M
Q4 2025
Shares
267.6K
% of Portfolio
+2.49%
Quarters Held
21
currently held
Position History TMO
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q4 2025 | 267.6K | $155M | +2.49% |
| Q3 2025 | 301.0K | $146M | +2.33% |
| Q2 2025 | 317.9K | $129M | +0.10% |
| Q1 2025 | 267.2K | $133M | +2.35% |
| Q4 2024 | 258.6K | $134M | +2.13% |
| Q3 2024 | 249.6K | $137M | +2.12% |
| Q2 2024 | 249.6K | $137M | +2.12% |
| Q1 2024 | 247.1K | $143M | +2.20% |
| Q4 2023 | 245.1K | $131M | +2.14% |
| Q3 2023 | 181.7K | $92M | +1.72% |
| Q2 2023 | 160.1K | $83M | +1.49% |
| Q1 2023 | 142.7K | $82M | +1.61% |
| Q4 2022 | 143.3K | $79M | +1.78% |
| Q3 2022 | 143.9K | $73M | +1.77% |
| Q1 2022 | 157.7K | $93M | +1.68% |
| Q4 2021 | 149.5K | $100M | +1.64% |
| Q3 2021 | 159.0K | $91M | +1.50% |
| Q2 2021 | 158.1K | $80M | +0.97% |
| Q1 2021 | 158.0K | $72M | +1.44% |
| Q4 2020 | 187.4K | $87M | +1.96% |
| Q3 2020 | 201.7K | $89M | +2.41% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Ccla Investment Management’s full portfolio or all institutional holders of TMO.